Page 101 - Rooster News Today

Data from a subanalysis of 30 sera from a Phase 2/3 clinical trial of children 5 through 11 years of age show a 36-fold increase in SARS-CoV-2 Omicron neutralizing titers following a booster (third) dose

Pfizer and BioNTech on Thursday announced positive results from a clinical trial on the safety and immune response of a third dose of their Covid vaccine in children aged five through 11, adding they would soon seek regulatory authorisation.

Pfizer/BioNTech say booster dose increases protection vs omicron in kids aged 5-11

Pfizer wants to expand its COVID-19 booster shots to healthy 5- to 11-year-olds.

The total doses administered now stand at 24.6 million

SII asks government to reduce time gap for Covid-19 vaccine booster dose - CEO noted that India and SII faced severe reputation damage when export of Covid vaccine was banned for nearly two months during second COVID wave.

The total doses administered now stand at 24.6 million

Booster dose drive of COVID-19 vaccination, which was started on Sunday, for the age group 18 to 59 years on its first day 9,674 precaution doses were administered across the nation, stated the Ministry of Health and Family Welfare on Monday.

Communist Party of India (CPI) Rajya Sabha MP from Kerala, Binoy Viswam has written a letter to Prime Minister Narendra Modi and urged him to reconsider the decision to provide booster doses to those aged above 18 years at a cost of around 375 rupees.

“We’re going to see that each individual is going to have to make their calculation of the amount of risk that they want to take in going to indoor dinners and in going to functions,” he said on ABC’s This Week.